Topas Therapeutics GmbH
Year founded
-
Country of origin
Germany
HQ country
Germany
Total deal value
Average deal value
Company industry
- Healthcare & Pharmaceuticals
M&A expertise
- -
Industry expertise
- Business Services
Topas Therapeutics GmbH emerges from the neuro portfolio of Bionamics GmbH which was acquired by Evotec AG in March 2014 and is an early stage therapeutics company using ground breaking nanoparticle technology to target autoimmune and inflammatory diseases via the induction of antigen specific immune tolerance in the liver.